IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Infinity Pharmaceuticals Inc (INFIQ)

CUSIP: 45665G303 | NYSE | 432 institutional holders

Quarters

Q4 2025Q3 2025Q1 2025Q3 2024Q2 2024
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2025

Motiv8 Investments LLC200
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Motiv8 Investments LLC
200$00.0%GrowthMediumPort St. Lucie, FL2026-02-13